SiBone (SIBN)
(Delayed Data from NSDQ)
$14.92 USD
-0.21 (-1.39%)
Updated May 17, 2024 04:00 PM ET
After-Market: $14.93 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SIBN 14.92 -0.21(-1.39%)
Will SIBN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for SIBN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SIBN
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?
SIBN: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Other News for SIBN
Noteworthy Friday Option Activity: SIBN, ZM, RCUS
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
SI-Bone expands portfolio with launch of new offering for iFuse Bedrock
A Closer Look at 6 Analyst Recommendations For SI-BONE
SI-Bone price target lowered by $1 at Morgan Stanley, here's why